Sponsors must take on FDA's diversity guidance to improve community trust

Retrieved on: 2024-07-01 19:16:23

Tags for this article:

Clinical research

Clinical trials

Design of experiments

Clinical pharmacology

Patient recruitment

United States

Shutterstock

Click the tags to see associated articles and topics

Sponsors must take on FDA's diversity guidance to improve community trust. View article details on hiswai:

Summary

The article discusses the FDA's recent guidance to improve diversity in clinical trials, touching on various aspects such as patient recruitment, site selection, and industry obligations. This highlights the role of business intelligence in enhancing clinical research processes.

Article found on: www.clinicaltrialsarena.com

View Original Article